Luigi Gradoni - Infectious Diseases

Author Information

Luigi Gradoni is a prominent researcher affiliated with the Unit of Vector-borne Diseases, Department of Infectious Diseases at the Istituto Superiore di Sanità, located in Rome, Italy. His extensive work primarily focuses on infectious diseases, particularly those transmitted by vectors such as sand flies and mosquitoes. Over the years, he has contributed significantly to the understanding and management of vector-borne diseases, including leishmaniasis and malaria.

Research Contributions

Luigi Gradoni has made substantial contributions to the field of infectious diseases through his research on vector-borne diseases. His work includes the development and evaluation of insecticidal treatments and vaccines aimed at controlling diseases like leishmaniasis. Gradoni's research also involves the surveillance and analysis of disease transmission patterns, as demonstrated by his studies on malaria and leishmaniasis in Europe. His efforts in developing guidelines for the evaluation of parasiticides underline his commitment to improving public health strategies for disease prevention and control.

Aliases

Luigi Gradoni is also known by variations of his name, including L. Gradoni and L Gradoni. These aliases are used interchangeably in academic publications.

Publication and Citation Metrics

Metric	Value
Total Citations	12,253
H-index	56
Total Papers	294

Publications:

Malaria surveillance system and Hospital Discharge Records: Assessing differences in Italy, 2011-2017 database analysis.

DOI: 10.1016/j.tmaid.2022.102322

Year: 2022

Surveillance of leishmaniasis cases from 15 European centres, 2014 to 2019: a retrospective analysis

DOI: 10.2807/1560-7917.ES.2022.27.4.2002028

Year: 2022

Insecticidal efficacy against Phlebotomus perniciosus in dogs treated orally with fluralaner in two different parallel-group, negative-control, random and masked trials

DOI: 10.1186/s13071-021-05128-z

Year: 2022

Laboratory evidence that dinotefuran, pyriproxyfen and permethrin combination abrogates Leishmania infantum transmissibility by sick dogs

DOI: 10.1111/mve.12553

Year: 2021

Examining the Relationship of Clinical and Laboratory Parameters With Infectiousness to Phlebotomus perniciosus and Its Potential Infectivity in Dogs With Overt Clinical Leishmaniasis

DOI: 10.3389/fvets.2021.667290

Year: 2021

World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for studies evaluating the efficacy of parasiticides in reducing the risk of vector-borne pathogen transmission in dogs and cats.

DOI: 10.1016/j.vetpar.2021.109369

Year: 2021

Monitoring Campaign over an Edible Dormouse Population (Glis glis; Rodentia: Gliridae) in Sicily: First Report of Mesocestodiasis

DOI: 10.3390/ani11040934

Year: 2021

Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant

DOI: 10.3390/microorganisms9112253

Year: 2021

Development of Various Leishmania (Sauroleishmania) tarentolae Strains in Three Phlebotomus Species

DOI: 10.3390/microorganisms9112256

Year: 2021

Elevated and sustained anti‐feeding effect of Scalibor® deltamethrin collar against the sand fly Phlebotomus perniciosus in dogs confirmed for 1 year following treatment

DOI: 10.1111/mve.12545

Year: 2021

What Are the Long-Term Outcomes for Infected Children?

What Happens After the Throat Swab is Collected?

How is Colonization Detected?

Why are Chest CT Scans Important in Infectious Diseases?

What are Isoprenoids?

How Can ARDS be Prevented in the Context of Infectious Diseases?

What Role Do Antimicrobial Resistance Play?

What is the Role of Prophylaxis in Malaria Control?

Can Aspirin Be Used for Fever Management?

How Do Masks Work?

Partnered Content Networks

Relevant Topics